Autoimmune‐PAP is characterised by the development of GM‐CSF antibodies that impair macrophage function leading to the accumulation of proteinaceous material in the alveolar space, neutrophil dysfunction, innate immune deficiency, and secondary infections with atypical organisms [1]. This evidence concerns the gene CSF2 and pulmonary alveolar proteinosis.